Center for Skin Research, Testing and Product Development

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Hidradenitis suppurativa1 trial
• Melanoma1 trial

Phase

• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Amgen1 trial
• Boehringer Ingelheim1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

  NCT06054555· Phase 3· Amgen· Source

Closed trials

• Completed

  Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

  NCT05819398· Phase 2/3· Boehringer Ingelheim· Source